13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 17 holding rows worth $82,561,114.
- Accession
- 0000950123-23-008083
- Filer
- CIK 1822947
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 17 entries on the cover page, a total value of $82,561,114 stated on the cover page (in dollars after the unit check, H1), rows summing to $82,561,114 with VALUE read as dollars as filed, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 105,558 | $10,762,694 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 487,631 | $10,308,519 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 266,961 | $10,277,999 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 223,382 | $7,286,721 | dollars as filed | |
| GERON CORP | 374163103 | COM | 2,123,162 | $6,815,350 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 199,221 | $5,245,489 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 201,752 | $4,799,680 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 91,413 | $4,662,063 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 390,418 | $4,239,939 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 800,000 | $4,040,000 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 3,200,000 | $3,680,000 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 2,517,232 | $3,448,608 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 914,630 | $2,908,523 | dollars as filed | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 5,894,897 | $1,444,839 | dollars as filed | |
| MDXHEALTH SA | 58286E102 | ADR | 349,552 | $1,191,972 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 653,396 | $1,045,434 | dollars as filed | |
| RAPID MICRO BIOSYSTEMS INC | 75340L104 | CLASS A COM | 403,284 | $403,284 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-008083 | this filing | 2023-08-14 | acceptance time not in the bulk data set |